In a small study, vitamin K antagonist use and liver dysfunction emerged as the most important factors in the development of calciphylaxis.
In an analysis of 2 randomized trials of patients with stage 3 to 4 chronic kidney disease, iPTH suppression did not occur until serum 25-hydroxyvitamin D rose to at least 50.8 ng/mL.
In a single center study, hungry bone syndrome developed in fewer patients on peritoneal dialysis than hemodialysis after parathyroidectomy.
In a study, patients with the highest preoperative levels of PTH tended to have higher postoperative levels than other transplant recipients.
In a study of patients with chronic kidney disease, secondary hyperparathyroidism was associated with high risk for reduced bone mineral density, particularly at the hip.
In a small study of hemodialysis patients with secondary hyperparathyroidism, microwave ablation achieved higher rates of the recommended target levels of intact parathyroid hormone.
Study supports the hypothesis that altered tubular phosphate handling drives the increase in serum phosphate during SGLT2 inhibition.
In a study, having the single nucleotide polymorphism rs11063112 in fibroblast growth factor 23 was associated with a 32% greater risk for cardiovascular mortality.
In a study of hemodialysis patients, vitamin D users had a lower mortality rate than nonusers: 9 vs 13 per 100 person-years.
Younger age, longer dialysis vintage, and black race are associated with greater cinacalcet prescribing in the United States.